Key facts
- This page summarizes Cambridge Equities, LP's Form 3 filing for Heliogen, Inc. (HLGN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 16:48.
Cambridge Equities, LP - 15 Feb 2024 Form 3 Insider Report for Heliogen, Inc. (HLGN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- HLGN
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- Reporting owner signature
- //s/ Charles Kenworthy, Manager of MP 13 Ventures, on behalf of itself and as General Partner of Cambridge Equities
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Cambridge Equities, LP filed Form 3 for Heliogen, Inc. (HLGN) on 20 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HLGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 442,298
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares owned by Cambridge Equities, LP ("Cambridge Equities"), who became a member of a "group" with Nant Capital LLC and Dr. Patrick Soon-Shiong for purposes of Section 13(d) of the Exchange Act. MP13 Ventures, LLC ("MP13 Ventures") is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the shares held by Cambridge Equities and Dr. Patrick Soon-Shiong is the sole member of MP13 Ventures. As a result, MP13 Ventures and Dr. Soon-Shiong may be deemed to beneficially own, and share with Cambridge Equities the power to vote and direct the vote, and the power to dispose or direct the disposition of, the shares owned by Cambridge Equities. The reporting owners disclaims beneficial ownership over the shares owned, except to the extent of their pecuniary interest.